| Item Type | Name |
|
Academic Article
|
The efficacy of catheters coated with minocycline and rifampin in the prevention of catheter-related bacteremia in cancer patients receiving high-dose interleukin-2.
|
|
Concept
|
Survival Rate
|
|
Concept
|
Humans
|
|
Concept
|
Antigens, Differentiation, T-Lymphocyte
|
|
Concept
|
Sarcoma
|
|
Concept
|
Colorectal Neoplasms, Hereditary Nonpolyposis
|
|
Concept
|
Interleukin-7 Receptor alpha Subunit
|
|
Concept
|
Receptors, CXCR3
|
|
Concept
|
Prostate
|
|
Concept
|
Antigen Presentation
|
|
Concept
|
Pilot Projects
|
|
Concept
|
Membrane Glycoproteins
|
|
Concept
|
Catheterization, Central Venous
|
|
Concept
|
Antibodies, Anti-Idiotypic
|
|
Concept
|
Injections, Intradermal
|
|
Concept
|
History, 20th Century
|
|
Concept
|
Cancer Care Facilities
|
|
Concept
|
Dactinomycin
|
|
Concept
|
Adaptor Proteins, Signal Transducing
|
|
Concept
|
Leukemic Infiltration
|
|
Concept
|
Urologic Neoplasms
|
|
Concept
|
Receptors, Interleukin-7
|
|
Concept
|
Lymphoma, Large B-Cell, Diffuse
|
|
Concept
|
Adoptive Transfer
|
|
Concept
|
Histone Demethylases
|
|
Concept
|
Erythema Nodosum
|
|
Concept
|
Lymphopoiesis
|
|
Concept
|
Autoantibodies
|
|
Concept
|
Carcinoma, Non-Small-Cell Lung
|
|
Concept
|
Inflammation
|
|
Concept
|
Mohs Surgery
|
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
|
Concept
|
Cytokines
|
|
Concept
|
Angiogenesis Inhibitors
|
|
Concept
|
Immunologic Factors
|
|
Concept
|
Anus Neoplasms
|
|
Concept
|
Vascular Endothelial Growth Factor A
|
|
Concept
|
Enzyme-Linked Immunosorbent Assay
|
|
Concept
|
Receptors, Antigen, T-Cell, alpha-beta
|
|
Concept
|
Neutrophils
|
|
Concept
|
T-Lymphocytes, Cytotoxic
|
|
Concept
|
Disease Models, Animal
|
|
Concept
|
Intestinal Mucosa
|
|
Concept
|
Precision Medicine
|
|
Concept
|
Minocycline
|
|
Concept
|
DNA Methylation
|
|
Concept
|
Interleukin-10
|
|
Concept
|
Hominidae
|
|
Concept
|
Anti-Bacterial Agents
|
|
Concept
|
Esophageal Neoplasms
|
|
Concept
|
Brain Neoplasms
|
|
Concept
|
Platinum
|
|
Concept
|
Transforming Growth Factor beta
|
|
Concept
|
Lung Neoplasms
|
|
Concept
|
RNA, Small Interfering
|
|
Concept
|
Antigens
|
|
Concept
|
Kaplan-Meier Estimate
|
|
Concept
|
Interferon-gamma
|
|
Concept
|
Receptors, IgG
|
|
Concept
|
Gorilla gorilla
|
|
Concept
|
Cell Lineage
|
|
Concept
|
Immunologic Surveillance
|
|
Concept
|
Chemokine CXCL13
|
|
Concept
|
Interleukin-2 Receptor alpha Subunit
|
|
Concept
|
GTP-Binding Protein alpha Subunits, Gi-Go
|
|
Concept
|
Receptors, Antigen, T-Cell
|
|
Concept
|
Melphalan
|
|
Concept
|
Drug Eruptions
|
|
Concept
|
Flow Cytometry
|
|
Concept
|
Hematopoietic Stem Cell Transplantation
|
|
Concept
|
CD8 Antigens
|
|
Concept
|
Incidence
|
|
Concept
|
Prostatic Neoplasms
|
|
Concept
|
CD4 Antigens
|
|
Concept
|
Proportional Hazards Models
|
|
Concept
|
Vaccines, DNA
|
|
Concept
|
Neoplasm Metastasis
|
|
Concept
|
Recurrence
|
|
Concept
|
PTEN Phosphohydrolase
|
|
Concept
|
Texas
|
|
Concept
|
Antigens, Differentiation
|
|
Concept
|
Mice, Inbred CBA
|
|
Concept
|
Magnetic Resonance Imaging
|
|
Concept
|
Oximes
|
|
Concept
|
Adrenal Gland Neoplasms
|
|
Concept
|
Intercellular Adhesion Molecule-1
|
|
Concept
|
Antigens, CD1
|
|
Concept
|
Immunophenotyping
|
|
Concept
|
Receptors, OX40
|
|
Concept
|
Arteriovenous Fistula
|
|
Concept
|
Antigens, Neoplasm
|
|
Concept
|
Confidence Intervals
|
|
Concept
|
Sirolimus
|
|
Concept
|
Adrenergic beta-Antagonists
|
|
Concept
|
Mice, Knockout
|
|
Concept
|
Feasibility Studies
|
|
Concept
|
Amino Acid Sequence
|
|
Concept
|
Antigens, Viral, Tumor
|
|
Concept
|
Statistics as Topic
|
|
Concept
|
Disease-Free Survival
|
|
Concept
|
Animals
|
|
Concept
|
Immunosuppressive Agents
|
|
Concept
|
Disease Susceptibility
|
|
Concept
|
Societies, Medical
|
|
Concept
|
Cytarabine
|
|
Concept
|
Esophagogastric Junction
|
|
Concept
|
T-Lymphocytes, Helper-Inducer
|
|
Concept
|
Macrophages
|
|
Concept
|
Radiosurgery
|
|
Concept
|
Antibodies, Monoclonal
|
|
Concept
|
Antigens, Surface
|
|
Concept
|
Bacteremia
|
|
Concept
|
Survival Analysis
|
|
Concept
|
Cluster Analysis
|
|
Concept
|
ATP-Binding Cassette Transporters
|
|
Concept
|
Receptor, Fibroblast Growth Factor, Type 3
|
|
Concept
|
ras Proteins
|
|
Concept
|
Reverse Transcriptase Polymerase Chain Reaction
|
|
Concept
|
Thymus Gland
|
|
Concept
|
Interleukin-1beta
|
|
Concept
|
Urogenital Neoplasms
|
|
Concept
|
Lymphocyte Activation
|
|
Concept
|
Preoperative Care
|
|
Concept
|
Glucocorticoid-Induced TNFR-Related Protein
|
|
Concept
|
Carcinoma
|
|
Concept
|
Autoantigens
|
|
Concept
|
Immunotherapy, Adoptive
|
|
Concept
|
Leukocytes, Mononuclear
|
|
Concept
|
Immunoconjugates
|
|
Concept
|
Carcinoma, Hepatocellular
|
|
Concept
|
Receptor, ErbB-2
|
|
Concept
|
Th1 Cells
|
|
Concept
|
Cyclophosphamide
|
|
Concept
|
Dietary Fiber
|
|
Concept
|
Carcinoma, Renal Cell
|
|
Concept
|
Clinical Trials, Phase I as Topic
|
|
Concept
|
CD8-Positive T-Lymphocytes
|
|
Concept
|
Lymphocyte Count
|
|
Concept
|
Fluorescent Antibody Technique
|
|
Concept
|
Urinary Bladder Neoplasms
|
|
Concept
|
Disease Progression
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
Mice, Inbred BALB C
|
|
Concept
|
Sensitivity and Specificity
|
|
Concept
|
History, 21st Century
|
|
Concept
|
Receptors, Interferon
|
|
Concept
|
Cohort Studies
|
|
Concept
|
Antibodies
|
|
Concept
|
Antineoplastic Agents
|
|
Concept
|
Databases, Genetic
|
|
Concept
|
Neoplasms, Experimental
|
|
Concept
|
Clinical Trials, Phase II as Topic
|
|
Concept
|
Colorectal Neoplasms
|
|
Concept
|
DNA Copy Number Variations
|
|
Concept
|
Lymphoma
|
|
Concept
|
Histocompatibility Antigens Class I
|
|
Concept
|
Pancreatic Neoplasms
|
|
Concept
|
T-Lymphocytes, Regulatory
|
|
Concept
|
Crohn Disease
|
|
Concept
|
Interleukin-4
|
|
Concept
|
Lymph Nodes
|
|
Concept
|
Carcinoma, Squamous Cell
|
|
Concept
|
Mice, Nude
|
|
Concept
|
Case-Control Studies
|
|
Concept
|
Chemokine CCL2
|
|
Concept
|
Leukemia, Myeloid, Acute
|
|
Concept
|
Histocompatibility Antigens Class II
|
|
Concept
|
CD4-Positive T-Lymphocytes
|
|
Concept
|
Prospective Studies
|
|
Concept
|
Antimetabolites, Antineoplastic
|
|
Concept
|
Kidney Neoplasms
|
|
Concept
|
Interleukin-6
|
|
Concept
|
Receptors, Immunologic
|
|
Concept
|
Human Body
|
|
Concept
|
Randomized Controlled Trials as Topic
|
|
Concept
|
Carcinoma, Pancreatic Ductal
|
|
Concept
|
Benzamides
|
|
Concept
|
5'-Nucleotidase
|
|
Concept
|
Chromosome Aberrations
|
|
Concept
|
H-2 Antigens
|
|
Concept
|
Th2 Cells
|
|
Concept
|
Fibrosis
|
|
Concept
|
Enzyme Inhibitors
|
|
Concept
|
Histocompatibility Antigens
|
|
Concept
|
Idarubicin
|
|
Concept
|
Breast Neoplasms
|
|
Concept
|
Chromosome Deletion
|
|
Concept
|
B-Lymphocytes
|
|
Concept
|
Monitoring, Immunologic
|
|
Concept
|
Stomach Neoplasms
|
|
Concept
|
B7-1 Antigen
|
|
Concept
|
Bone Neoplasms
|
|
Concept
|
Genetic Predisposition to Disease
|
|
Concept
|
Disease Management
|
|
Concept
|
Jumonji Domain-Containing Histone Demethylases
|
|
Concept
|
T-Lymphocyte Subsets
|
|
Concept
|
Carcinoma, Transitional Cell
|
|
Concept
|
Biopsy
|
|
Concept
|
Epitopes, T-Lymphocyte
|
|
Concept
|
Dose-Response Relationship, Drug
|
|
Concept
|
Infusions, Intravenous
|
|
Concept
|
Head and Neck Neoplasms
|
|
Concept
|
Lymphocytes, Tumor-Infiltrating
|
|
Concept
|
Phenylthiohydantoin
|
|
Concept
|
Chromosomes, Human, Pair 7
|
|
Concept
|
Mice
|
|
Concept
|
Clinical Trials as Topic
|
|
Concept
|
Gene Expression Regulation, Leukemic
|
|
Concept
|
Carcinoma, Medullary
|
|
Concept
|
Immunomodulation
|
|
Concept
|
Adenocarcinoma
|
|
Concept
|
Pyrroles
|
|
Concept
|
Lymphatic Metastasis
|
|
Concept
|
Probiotics
|
|
Concept
|
Angiography
|
|
Concept
|
United States
|
|
Concept
|
Hodgkin Disease
|
|
Concept
|
Vaccination
|
|
Concept
|
Risk Assessment
|
|
Concept
|
Skin Neoplasms
|
|
Concept
|
Perioperative Care
|
|
Concept
|
Testis
|
|
Concept
|
Risk
|
|
Concept
|
Risk Factors
|
|
Concept
|
Phosphatidylinositol 3-Kinases
|
|
Concept
|
Deoxycytidine
|
|
Concept
|
Azacitidine
|
|
Concept
|
Leukemia, Lymphocytic, Chronic, B-Cell
|
|
Concept
|
Base Sequence
|
|
Concept
|
Follow-Up Studies
|
|
Concept
|
Tissue Array Analysis
|
|
Concept
|
Killer Cells, Natural
|
|
Concept
|
Interferon Type I
|
|
Concept
|
Gene Knockdown Techniques
|
|
Concept
|
Immunohistochemistry
|
|
Concept
|
Glioblastoma
|
|
Concept
|
Immune Tolerance
|
|
Concept
|
Italy
|
|
Concept
|
Mice, Mutant Strains
|
|
Concept
|
Neuroimmunomodulation
|
|
Concept
|
Melanoma
|
|
Concept
|
Dendritic Cells, Follicular
|
|
Concept
|
Neoplasm Recurrence, Local
|
|
Concept
|
Adjuvants, Immunologic
|
|
Concept
|
Mice, Inbred C57BL
|
|
Concept
|
Karnofsky Performance Status
|
|
Concept
|
Small Cell Lung Carcinoma
|
|
Concept
|
Interleukin-7
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
Paraffin Embedding
|
|
Concept
|
Proto-Oncogene Proteins c-akt
|
|
Concept
|
Melanoma, Experimental
|
|
Concept
|
Pan troglodytes
|
|
Concept
|
Liver Neoplasms
|
|
Concept
|
Mice, Transgenic
|
|
Concept
|
Cell Separation
|
|
Concept
|
T-Lymphocytes
|
|
Concept
|
Receptors, Antigen, T-Cell, gamma-delta
|
|
Concept
|
Granulocyte-Macrophage Colony-Stimulating Factor
|
|
Concept
|
Lymphocyte Culture Test, Mixed
|
|
Concept
|
Quality of Life
|
|
Concept
|
Antigens, CD
|
|
Concept
|
Epitopes
|
|
Concept
|
Neoplasm Invasiveness
|
|
Concept
|
Monocytes
|
|
Concept
|
Testicular Neoplasms
|
|
Concept
|
Interleukin-2
|
|
Concept
|
Yttrium Radioisotopes
|
|
Concept
|
Endometrial Neoplasms
|
|
Concept
|
Intestine, Small
|
|
Concept
|
Immunoglobulin G
|
|
Concept
|
Xenograft Model Antitumor Assays
|
|
Concept
|
Severity of Illness Index
|
|
Concept
|
RNA, Messenger
|
|
Concept
|
Immunologic Memory
|
|
Concept
|
Genes, MHC Class I
|
|
Academic Article
|
Immune responses detected in urothelial carcinoma patients after vaccination with NY-ESO-1 protein plus BCG and GM-CSF.
|
|
Academic Article
|
Review of metastatic bladder cancer.
|
|
Academic Article
|
Cancer-testis antigens: expression and correlation with survival in human urothelial carcinoma.
|
|
Academic Article
|
The ICOS/ICOSL pathway is required for optimal antitumor responses mediated by anti-CTLA-4 therapy.
|
|
Academic Article
|
The future of immune checkpoint therapy.
|
|
Academic Article
|
A pilot study of preoperative single-dose ipilimumab and/or cryoablation in women with early-stage breast cancer with comprehensive immune profiling
|
|
Academic Article
|
A Pilot Study of Preoperative Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer with Comprehensive Immune Profiling.
|
|
Academic Article
|
Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies.
|
|
Academic Article
|
VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer.
|
|
Academic Article
|
Erratum: Effective combinatorial immunotherapy for castration-resistant prostate cancer.
|
|
Academic Article
|
Effective combinatorial immunotherapy for castration-resistant prostate cancer.
|
|
Academic Article
|
The emerging role of immune checkpoint based approaches in AML and MDS.
|
|
Academic Article
|
Negative Co-stimulation Constrains T Cell Differentiation by Imposing Boundaries on Possible Cell States.
|
|
Concept
|
Bevacizumab
|
|
Concept
|
Everolimus
|
|
Concept
|
Pemetrexed
|
|
Concept
|
Imatinib Mesylate
|
|
Concept
|
Gastrointestinal Microbiome
|
|
Concept
|
Autoimmune Hypophysitis
|
|
Concept
|
Pharmacogenomic Testing
|
|
Concept
|
Enhancer of Zeste Homolog 2 Protein
|
|
Concept
|
Tertiary Lymphoid Structures
|
|
Concept
|
Antineoplastic Agents, Immunological
|
|
Concept
|
Ipilimumab
|
|
Concept
|
Intraepithelial Lymphocytes
|
|
Concept
|
GPI-Linked Proteins
|
|
Concept
|
gp100 Melanoma Antigen
|
|
Concept
|
B7 Antigens
|
|
Concept
|
Inducible T-Cell Co-Stimulator Protein
|
|
Concept
|
B7-H1 Antigen
|
|
Concept
|
V-Set Domain-Containing T-Cell Activation Inhibitor 1
|
|
Concept
|
CTLA-4 Antigen
|
|
Concept
|
Inducible T-Cell Co-Stimulator Ligand
|
|
Concept
|
Costimulatory and Inhibitory T-Cell Receptors
|
|
Concept
|
Programmed Cell Death 1 Receptor
|
|
Concept
|
Antibodies, Monoclonal, Humanized
|
|
Concept
|
Prostatic Neoplasms, Castration-Resistant
|
|
Concept
|
Triple Negative Breast Neoplasms
|
|
Concept
|
Multimodal Imaging
|
|
Concept
|
Response Evaluation Criteria in Solid Tumors
|
|
Concept
|
Cardiotoxicity
|
|
Concept
|
ErbB Receptors
|
|
Academic Article
|
Fibroblast Growth Factor Receptor 3 Alterations and Response to PD-1/PD-L1 Blockade in Patients with Metastatic Urothelial Cancer.
|
|
Academic Article
|
Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages.
|
|
Academic Article
|
Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma.
|
|
Academic Article
|
B cells and tertiary lymphoid structures promote immunotherapy response.
|
|
Academic Article
|
Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer.
|
|
Academic Article
|
Nivolumab in Patients with Advanced Platinum-resistant Urothelial Carcinoma: Efficacy, Safety, and Biomarker Analyses with Extended Follow-up from CheckMate 275.
|
|
Academic Article
|
ARID1A mutation plus CXCL13 expression act as combinatorial biomarkers to predict responses to immune checkpoint therapy in mUCC.
|
|
Academic Article
|
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial.
|
|
Academic Article
|
Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer.
|
|
Academic Article
|
Hallmarks of response, resistance, and toxicity to immune checkpoint blockade.
|
|
Academic Article
|
Hallmarks of response, resistance, and toxicity to immune checkpoint blockade.
|
|
Academic Article
|
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity.
|
|
Academic Article
|
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial.
|